CollPlant Biotechnologies (CLGN) Debt to Equity (2018 - 2020)
Historic Debt to Equity for CollPlant Biotechnologies (CLGN) over the last 3 years, with Q4 2020 value amounting to -$0.74.
- CollPlant Biotechnologies' Debt to Equity rose 4873.57% to -$0.74 in Q4 2020 from the same period last year, while for Dec 2020 it was -$0.74, marking a year-over-year increase of 4873.57%. This contributed to the annual value of -$0.74 for FY2020, which is 4873.57% up from last year.
- Latest data reveals that CollPlant Biotechnologies reported Debt to Equity of -$0.74 as of Q4 2020, which was up 4873.57% from -$0.44 recorded in Q2 2020.
- CollPlant Biotechnologies' 5-year Debt to Equity high stood at -$0.44 for Q4 2018, and its period low was -$1.45 during Q4 2019.
- Over the past 3 years, CollPlant Biotechnologies' median Debt to Equity value was -$0.59 (recorded in 2020), while the average stood at -$0.77.
- Per our database at Business Quant, CollPlant Biotechnologies' Debt to Equity tumbled by 23235.53% in 2019 and then soared by 4873.57% in 2020.
- Quarter analysis of 3 years shows CollPlant Biotechnologies' Debt to Equity stood at -$0.44 in 2018, then plummeted by 232.36% to -$1.45 in 2019, then surged by 48.74% to -$0.74 in 2020.
- Its last three reported values are -$0.74 in Q4 2020, -$0.44 for Q2 2020, and -$1.45 during Q4 2019.